Bloomberg:
#UK #drugmaker #AstraZeneca plans to invest $50 billion in the US before 2030, ratcheting up spending alongside other
#European #pharmaceutical #companies ahead of looming
#tariffs on
#imported #medicines.
GSK Plc will pay
#23andMe Holding Co. $20M for
#GeneticTesting company’s vast
#trove of
#consumer #DNAData, extending a 5 yr collaboration that’s allowed the
#drugmaker to mine
#geneticdata as it researches new
#medications. Under the new agreement, 23andMe will provide GSK with one year of access to anonymized
#DNA data from the approximately 80% of gene-testing customers who have agreed to share their information for research. Really?
#privacy #medicine #healthcare https://www.bloomberg.com/news/articles/2023-10-30/23andme-will-give-gsk-access-to-consumer-dna-data
23andMe Will Give GSK Access to Consumer DNA Data
GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.
Bloomberg#FDA Approves Most Expensive #Drug Ever, a $3.5 Million-per-Dose Gene Therapy For blood-clotting disorder Hemophilia B
#Hemgenix is an IV treatment for adults with #hemophiliaB, which primarily affects men.
#Drugmaker CSL Behring announced the price saying its drug would ultimately reduce health care costs because #patients would have fewer bleeding incidents and need fewer clotting #treatments.
#illness #HealthCare #Healh #Pharma #CorporateHealthCare
https://science.slashdot.org/story/22/11/24/2126237/fda-approves-most-expensive-drug-ever-a-35-million-per-dose-gene-therapy-for-hemophilia-b

FDA Approves Most Expensive Drug Ever, a $3.5 Million-per-Dose Gene Therapy For Hemophilia B - Slashdot
U.S. health regulators this week approved the first gene therapy for hemophilia, a $3.5 million one-time treatment for the blood-clotting disorder. From a report: The Food and Drug Administration cleared Hemgenix, an IV treatment for adults with hemophilia B, the less common form of the genetic diso...

COVID-19 Vaccine-Maker Hit with Cyberattack, Data Breach
Dr. Reddy's, the contractor for Russia’s “Sputinik V” COVID-19 vaccine and a major generics producer, has had to close plants and isolate its data centers.
Threatpost - English - Global - threatpost.com